Real-World Effectiveness of Insulin Glargine 300 Initiation in Switzerland

INTRODUCTION: Insulin glargine 300 U/mL (Gla-300; Toujeo(®)) is a second-generation once-daily basal insulin. Previous randomized controlled trials showed comparable HbA1c reductions with lower rates of hypoglycemia of Gla-300 versus Gla-100. PATIENTS AND METHODS: We report the 12 months results of...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomann, Robert, Zechmann, Stefan, Alexander-David, Nicola, Jornayvaz, François R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342388/
https://www.ncbi.nlm.nih.gov/pubmed/32753920
http://dx.doi.org/10.2147/DMSO.S252667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342388/
https://www.ncbi.nlm.nih.gov/pubmed/32753920
http://dx.doi.org/10.2147/DMSO.S252667

Ejemplares similares